Polymer Nanofiber-Embedded Microchips for Detection, Isolation, and Molecular Analysis of Single Circulating Melanoma Cells

Authors

  • Dr. Shuang Hou,

    1. Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging (CIMI), California NanoSystems Institute (CNSI), University of California, Los Angeles, 570 Westwood Plaza, Building 114, Los Angeles, CA 90095-1770 (USA) http://www.tseng-lab.com
    Search for more papers by this author
    • These authors contributed equally to the work.

  • Dr. Libo Zhao,

    1. Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging (CIMI), California NanoSystems Institute (CNSI), University of California, Los Angeles, 570 Westwood Plaza, Building 114, Los Angeles, CA 90095-1770 (USA) http://www.tseng-lab.com
    Search for more papers by this author
    • These authors contributed equally to the work.

  • Qinglin Shen,

    1. Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging (CIMI), California NanoSystems Institute (CNSI), University of California, Los Angeles, 570 Westwood Plaza, Building 114, Los Angeles, CA 90095-1770 (USA) http://www.tseng-lab.com
    2. Department of Applied Physics and Department of Oncology Surgery, Wuhan University, Wuhan (P.R. China)
    Search for more papers by this author
    • These authors contributed equally to the work.

  • Dr. Juehua Yu,

    1. Department of Surgery, University of California, Los Angeles (USA)
    Search for more papers by this author
    • These authors contributed equally to the work.

  • Charles Ng,

    1. Division of Hematology and Oncology, Department of Medicine, Department of Surgery, and Department of Molecular and Medical Pharmacology, University of California, Los Angeles (USA)
    Search for more papers by this author
  • Xiangju Kong,

    1. Division of Dermatology, Department of Medicine, University of California, Los Angeles
    Search for more papers by this author
  • Dr. Dongxia Wu,

    1. Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging (CIMI), California NanoSystems Institute (CNSI), University of California, Los Angeles, 570 Westwood Plaza, Building 114, Los Angeles, CA 90095-1770 (USA) http://www.tseng-lab.com
    Search for more papers by this author
  • Dr. Min Song,

    1. Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging (CIMI), California NanoSystems Institute (CNSI), University of California, Los Angeles, 570 Westwood Plaza, Building 114, Los Angeles, CA 90095-1770 (USA) http://www.tseng-lab.com
    Search for more papers by this author
  • Dr. Xiaohong Shi,

    1. Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging (CIMI), California NanoSystems Institute (CNSI), University of California, Los Angeles, 570 Westwood Plaza, Building 114, Los Angeles, CA 90095-1770 (USA) http://www.tseng-lab.com
    Search for more papers by this author
  • Xiaochun Xu,

    1. CytoLumina Technologies Corp. 21038 Commerce Point Dr., Walnut, CA 91789 (USA)
    Search for more papers by this author
  • Wei-Han OuYang,

    1. CytoLumina Technologies Corp. 21038 Commerce Point Dr., Walnut, CA 91789 (USA)
    Search for more papers by this author
  • Rongxian He,

    1. Department of Applied Physics and Department of Oncology Surgery, Wuhan University, Wuhan (P.R. China)
    Search for more papers by this author
  • Prof. Xing-Zhong Zhao,

    1. Department of Applied Physics and Department of Oncology Surgery, Wuhan University, Wuhan (P.R. China)
    Search for more papers by this author
  • Tom Lee,

    1. Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging (CIMI), California NanoSystems Institute (CNSI), University of California, Los Angeles, 570 Westwood Plaza, Building 114, Los Angeles, CA 90095-1770 (USA) http://www.tseng-lab.com
    Search for more papers by this author
  • Prof. F. Charles Brunicardi,

    1. Department of Surgery, University of California, Los Angeles (USA)
    Search for more papers by this author
  • Dr. Mitch André Garcia,

    Corresponding author
    1. CytoLumina Technologies Corp. 21038 Commerce Point Dr., Walnut, CA 91789 (USA)
    • CytoLumina Technologies Corp. 21038 Commerce Point Dr., Walnut, CA 91789 (USA)
    Search for more papers by this author
  • Prof. Antoni Ribas,

    Corresponding author
    1. Division of Hematology and Oncology, Department of Medicine, Department of Surgery, and Department of Molecular and Medical Pharmacology, University of California, Los Angeles (USA)
    • Division of Hematology and Oncology, Department of Medicine, Department of Surgery, and Department of Molecular and Medical Pharmacology, University of California, Los Angeles (USA)
    Search for more papers by this author
  • Prof. Roger S. Lo,

    Corresponding author
    1. Division of Dermatology, Department of Medicine, University of California, Los Angeles
    • Division of Dermatology, Department of Medicine, University of California, Los Angeles
    Search for more papers by this author
  • Prof. Hsian-Rong Tseng

    Corresponding author
    1. Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging (CIMI), California NanoSystems Institute (CNSI), University of California, Los Angeles, 570 Westwood Plaza, Building 114, Los Angeles, CA 90095-1770 (USA) http://www.tseng-lab.com
    • Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging (CIMI), California NanoSystems Institute (CNSI), University of California, Los Angeles, 570 Westwood Plaza, Building 114, Los Angeles, CA 90095-1770 (USA) http://www.tseng-lab.com
    Search for more papers by this author

  • This research was supported by the National Institutes of Health (R21 CA151159 and R33 CA157396). Dr. F. Charles Brunicardi, Dr. Antoni Ribas, Dr. Roger S. Lo, and Dr. Hsian-Rong Tseng are members of UCLA Josson Comprehensive Cancer Center. They acknowledge generous support from JCCC and promotion of the collaboration.

Abstract

original image

Eine Methode zur Detektion und Isolierung einzelner zirkulierender Melanomzellen (CMCs; siehe Bild) beruht auf der Kombination eines in eine Polymer-Nanofaser eingebetteten „Nanoklettband“-Zellaffinitätsassays mit Laser-Mikrodissektion (LMD). Für eine personalisiertere Krebstherapie lassen sich so CMCs von normalen weißen Blutzellen (WBCs) abtrennen und einzelne Zellen hinsichtlich einer bestimmten, mit dem Fortschreiten der Krankheit assoziierten Mutation sequenzieren.

Ancillary